The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CA19-9 for the prediction of efficacy of chemotherapy in patients with advanced pancreas cancer: A pooled analysis of six prospective trials.
T. M. Bauer
No relevant relationships to disclose
T. S. Bekaii-Saab
No relevant relationships to disclose
X. Li
No relevant relationships to disclose
M. A. Villalona-Calero
No relevant relationships to disclose
P. A. Philip
No relevant relationships to disclose
A. F. Shields
No relevant relationships to disclose
M. M. Zalupski
No relevant relationships to disclose
N. Hammad
No relevant relationships to disclose
B. F. El-Rayes
No relevant relationships to disclose